Written by
Phil Grainger
Bhvita Jani
Share article:
Q Bio Inc. has secured $27M in funding to bring its full-body MRI scanner to market. Q Bio claims that its Mark I scanner is a “groundbreaking advancement in MRI technology” and will overcome the challenges associated with conventional MRI hardware to facilitate preventative healthcare at a population scale.
Why we are covering this topic
- Full-body MRI scans for preventative healthcare are a controversial concept. A public endorsement from celebrity Kim Kardashian and high-profile investment from Spotify founder Daniel Ek sparked debate over the emerging sector late last year.
- Despite concerns around the practice, there is considerable investor appetite for companies in this space.
Why it matters
- Q Bio could disrupt the burgeoning market, and its technology may have an impact on the wider clinical MRI market if it can live up to its promises.
- Established modality vendors will be paying close attention to the market and considering how to position themselves if and when the opportunity matures.
Read the full insight with a Signify Premium Insights - Medical Imaging subscription
